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Abstract
Purpose We conducted this study to gauge the health-related
problems, quality of life and the performance of the Health
Utility Index Mark 3 (HUI-3) in patients with syndromic and
complex craniosynostosis. Patients with syndromic and com-
plex craniosynostosis have various physical and mental prob-
lems. More insight on these problems, per syndrome, could
provide guidance to improve patient treatment and follow-up.
Methods A cross-sectional, comparative study on 131
patients and their parents was performed. Health-related
quality of life was measured with the HUI-3 and the Visual
Analogue Scale (VAS). All data were compared to a norma-
tive Dutch population. Vision, hearing and intelligence were
objectively measured.
Results The HUI-3 and the VAS were significant lower
compared to the normative Dutch population. All syndromes
have a high prevalence of vision and speech problems. Cog-
nitive problems were mainly reported in patients with Apert,
Crouzon and Muenke syndrome. Ambulation and dexterity
problems were seen in Apert, Crouzon, Saethre–Chotzen and
complex craniosynostosis. Only patients with Apert syndrome
scored significantly worse on pain. The HUI-3 had a medium
to strong correlation with the objectively measured outcomes.
Conclusions The overall quality of life is lower in patients
with syndromic and complex craniosynostosis. To improve
quality of life, more attention is needed for problems with
vision and speech.
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Introduction
Craniosynostosis involves the premature closure of the cranial
sutures. In about 40% of the patients, it is part of a syndrome
such as Apert, Crouzon, Muenke and Saethre–Chotzen.
Patients with syndromic and complex craniosynostosis have
a lower health related quality of life (HRQoL), while patients
with isolated craniosynostosis score within the normal range
for quality of life and behavioral problems [3]. Reasons for the
lower HRQoL are problems concerning physical functioning,
bodily pain and mental health [1]. Commonly reported health-
related problems in syndromic craniosynostosis are hearing
and visual disorders, sleep apnea and hand and foot anomalies
[11]. The prevalence and severity of these problems vary per
syndrome, and it is unknown to what extent they influence
the HRQoL and parents perceived quality of life. The aim of
this study was to evaluate health related problems, quality of
life and the performance of the Health Utility Index Mark 3
(HUI-3) in patients with syndromic craniosynostosis.
Material and methods
A cross-sectional comparative study was performed in
patients 4–18 years of age, with a diagnosis of syndromic
or complex craniosynostosis. All patients were treated at the
craniofacial unit of a tertiary pediatric hospital. Patients
were included in the study if they had craniosynostosis
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associated with Apert, Crouzon, Pfeiffer, Saethre–Chotzen,
Muenke syndrome or complex craniosynostosis. Syndrome
diagnosis was based on genetic testing. Complex craniosy-
nostosis was defined as the premature closure of two or
more sutures in the absence of a genetic mutation. Because
Crouzon and Pfeiffer syndrome cannot be distinguished
from each other genetically, they were considered a homo-
geneous group in this study.
The health-related quality of life was assessed using the
HUI-3 questionnaire [13, 14]. The HUI is developed to mea-
sure health-related quality of life and is applicable in clinical
studies. The HUI is suitable for patients of 5 years and older,
and for children under the age of 8 years a proxy assessment is
recommended. Because we approached a large group of
patients younger than 8 years and there is a high prevalence
of cognitive impairment in patients with syndromic craniosy-
nostosis, we requested the parents to complete the question-
naire. Patients were compared to normative data from a
general Dutch population survey.15 It were also the parents
who completed the questionnaire in the Dutch population
survey. Based on the questionnaire, subjects were classified
according to the HUI-3 classification system. The HUI is a
utility (preference) based scoring system for measuring com-
prehensive health status and health-related quality of life,
consisting of eight attributes. Each attribute was scored from
1 (no limitations) to 4, 5 or 6 (severe limitations). Single
attribute utility scores range from 1.00 to 0.00, where perfect
health is 1.00 and dead is 0.00. Multi-attribute utility scores,
indicating overall health, are calculated based on single attri-
bute scores [8, 18]. The multi-attribute HUI score can be
negative, which indicates a state described as worse than dead.
Next to the HUI, the Visual Analogue Scale (VAS) was used to
rate parent-perceived overall health of the child, with a score
ranging from 0 (worst health) to 100 (best health). The ques-
tionnaire was once sent by mail once.
From the eight attributes of the HUI-3, vision, hearing
and intelligence can be measured objectively. Therefore, we
collected data of vision, hearing and intelligence to compare
to the corresponding HUI-3 attributes. Data of vision was
retrospectively collected. Vision is routinely checked with a
Snellen chart by our pediatric ophthalmologist. Data of
hearing was cross-sectionally gathered as part of another
study [5]. Hearing was tested by a pediatric audiologist with
pure tone audiometry. Hearing loss was expressed as the
average hearing loss at 500, 1,000 and 2,000 Hz of the best
ear. Intelligence was tested by a pediatric psychologist with
the Wechsler Intelligence Scale for Children (WISC)-III, as
part of a prospective study.
Statistical analysis
Mann–Whitney U-test was used to compare means within
the syndrome groups and between the syndrome groups and
the normative population. Pearson’s chi-square test was
used to test correlation. A two-sided p≤0.05 was considered
significant. All analyses were performed using SPSS 16.0
(SPSS Inc., Chicago, IL, USA).
Results
A total of 173 patients were approached, of whom 131
responded (76%). Of the 131 patients, 20 had Apert, 39 Crou-
zon/Pfeiffer, 25 Muenke, 18 Saethre–Chotzen and 29 complex
craniosynostosis. The mean age of the patients at the time of
this review was 9.6 years, and 45% were female. The average
age of the respondents was 41.6 years, and 73% were female
(see Table 1). There was no significant difference between how
mothers and fathers scored the HUI-3 and VAS, in the norma-
tive Dutch population and craniosynostosis groups. Age and
gender did not influence quality of life, except for Apert syn-
drome, were the males had a significant lower HUI-3.
The percentage of patients who are not affected and the
mean single attribute HUI-3 scores are shown in Table 2.
Patients were considered to be not affected if they had the
best possible score for that specific attribute. Vision, speech
and cognition were the most affected attributes in patients
with syndromic craniosynostosis. Speech was significant
associated with hearing (p<0.001) and cognition (p<0.001).
The mean VAS and multi-attribute HUI-3 score are shown
in Table 3. There was no significant difference between the
multi-attribute score and the VAS except for the Apert syn-
drome, in whom the HUI-3 was significant lower. This differ-
ence indicates that parents subjectively experience a higher
Table 1 Characteristics of patients and the normative population
Apert
(n=20)
Crouzon
(n=39)
Muenke
(n=25)
Saethre-
Chotzen
(n=18)
Complex
(n=29)
Norm group
(n=1435)
Sex patient M/F 8/12 18/21 11/14 5/13 17/12 708/727
Age patients in years, mean (SD) 10.6 (4.9) 9.5 (3.9) 9.3 (4.1) 10.4 (3.9) 8.7 (4.0) 8.1 (2.4)
Sex parent M/F 6/14 9/30 6/19 4/14 7/22 206/1229
Age parent in years, mean (SD) 41.6 (8.0) 41.8 (5.3) 40.5 (6.3) 43.3 (7.9) 41.3 (6.0) 37.7 (5.2)
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quality of life for their child than their objective scoring
indicates. The correlation between the multi-attribute HUI-3
and the VAS was 0.476 (p<0.001) in patients with
craniosynostosis.
Of the 131 included patients, 68 (52%) had data on
vision, 63 (48%) on hearing and 60 (46%) were tested with
the WISC-III. The correlation between the objective meas-
urements and the single-attributes was 0.558 (p<0.001) for
vision, −0.345 (p00.006) for hearing and 0.418 (p00.001)
for intelligence.
Discussion
The multi-attribute HUI-3 and the VAS are significantly lower
in patients with craniosynostosis compared to the normative
Dutch population. Themain reasons for this are problemswith
vision and speech, and cognition in Apert and Crouzon syn-
drome. Ambulation, emotional problems and pain have no or
limited influence on the HRQoL in syndromic craniosynos-
tosis. In general, age and gender did not influence the quality
of life. The overall correlation between the objective measure-
ments and the HUI-3 attributes is medium to strong.
Most problems were found in the attributes vision,
speech and cognition, despite routine screening for these
impairments in our patients. This screening and treatment
is thus essential but cannot prevent or overcome all restric-
tions. Problems with vision affect about half the patients and
can be due to refractive error, strabismus, astigmatism and
persistent elevated intracranial pressure [2, 4, 10, 12]. Speech
problems have previous been reported in Apert, Muenke and
Saethre–Chotzen syndrome [6, 7, 17]. Causes for speech
problems are hearing deficits, oral anomalies, learning dis-
abilities and impaired social interaction [17]. The impaired
cognition is probably not the main reason for speech problems
but will contribute to a worse language development [17]. The
level of intelligence varies strongly per syndrome but also
within every syndrome, especially patients with Apert syn-
drome can have a low intelligence [9, 15, 19, 20].
The single-attribute HUI-3 had a medium to strong cor-
relation with the objectively measured vision, hearing and
intelligence. However, in individual cases, there were large
differences between how parents scored the vision, hearing
or intelligence and the objective measurements. It is known
that parents have difficulty judging their child’s hearing
[16]. Therefore, we conclude that the HUI-3 is less suitable
in individual patients for follow-up, but can be used on a
group level for patients with syndromic craniosynostosis.
A limitation of this study is that although this is one of
the largest reported groups of children with syndromic cra-
niosynostosis, the syndrome-specific groups still have a
small sample size, making comparisons within groups not
more than explanatory. Another limitation is the cross-
sectional design of this study.
In conclusion, the overall quality of life is lower in
patients with syndromic and complex craniosynostosis. To
improve quality of life more attention is needed for problems
Table 3 Mean multi-attribute score of the HUI-3 and VAS
HUI-3 VAS
Apert (n020), mean (SD) 0.44* (0.30) 0.77 (0.20)
Crouzon (n039), mean (SD) 0.76 (0.23) 0.79 (0.18)
Muenke (n025), mean (SD) 0.81 (0.22) 0.81 (0.16)
Saethre–Chotzen (n018), mean (SD) 0.87 (0.14) 0.88 (0.11)
Complex (n029), mean (SD) 0.83 (0.24) 0.87 (0.10)
Total craniosynostosis group
(n0132), mean (SD)
0.75 (0.27)± 0.82 (0.16)±
Norm group (n01435), mean (SD) 0.91 (0.12) 0.93 (0.09)
*Significantly lower compared to VAS, p<0.05
± Significantly lower compared to norm group, p<0.001
Table 2 Mean single-attribute HUI-3 of patients and the normative population
Apert (n020) Crouzon (n039) Muenke (n025) Saethre–Chotzen
(n018)
Complex (n029) Norm group
(n01435)
HUI-3 % not
affected
Mean % not
affected
Mean % not
affected
Mean % not
affected
Mean % not
affected
Mean % not
affected
Mean
Vision 50 0.90± 50 0.90± 60 0.97± 31 0.96± 72 0.99± 93 0.99
Hearing 85 0.93± 79 0.93± 76 0.93± 89 0.96# 93 0.98* 98 1.00
Speech 20 0.68± 56 0.84± 56 0.84± 71 0.95* 66 0.87± 88 0.97
Ambulation 85 0.97± 90 0.96± 100 1.00 100 1.00 93 0.96± 99 1.00
Dexterity 0 0.58± 90 0.95± 100 1.00 94 0.98# 93 0.96± 99 1.00
Emotion 80 0.97 71 0.97 71 0.97 76 0.98 83 0.98 81 0.98
Cognition 25 0.77± 61 0.93± 72 0.89* 78 0.97 72 0.94 84 0.97
Pain 55 0.93# 73 0.97 76 0.96 76 0.98 79 0.97 81 0.98
*p<0.05, # p<0.01, ± p<0.001 compared to norm group
Childs Nerv Syst (2012) 28:879–882 881
with vision and speech. As there can be a big discrepancy
between objective measures and how parents score the HUI-3,
this questionnaire is more suitable for groups than for individ-
ual follow-up.
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